查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085864

體外受精市場：2026-2032年全球市場預測（按產品類型、胚胎來源、流程、應用和最終用戶分類）

In-Vitro Fertilization Market by Product, Embryo Source, Procedure Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，體外受精市場規模將達到 274.9 億美元，複合年成長率為 10.81%。

主要市場統計數據
基準年 2025 134億美元
預計年份：2026年 147.8億美元
預測年份 2032 274.9億美元
複合年成長率 (%) 10.81%

不孕症是一個重大的公共衛生和人口挑戰。世界衛生組織（世衛組織）估計，大約六分之一的成年人在其一生中的某個階段會經歷不孕不育，這使得體外受精（IVF）、胞漿內單精子注射（ICSI）、生育力保存、捐精以及在法律允許的情況下進行的胚胎胚胎著床前遺傳學檢測等技術的需求持續存在。

根據歐洲人類生殖與胚胎學會 (ESHRE) 和國際輔助生殖技術中心 (ICMART) 廣泛引用的估計，自 1978 年首例體外受精嬰兒出生以來，輔助生殖技術已使全球超過 1,000 萬名嬰兒誕生。需求受多種因素影響，例如延遲生育、母親年齡、男性不孕、癌症治療背景下的生殖功能保存、LGBTQ+ 家庭組成的選擇以及社會對生殖醫學日益成長的接受度。

對於行業領導者而言，體外受精的成功越來越取決於實證結果、經濟性、檢查室標準化、監管機構的信任以及患者體驗。競爭優勢正轉向透明的成功率報告、數位化驅動的醫療服務、安全的生殖健康數據系統以及能夠在多個地點保持品質的擴充性胚胎學運作。

體外受精（IVF）產業的變革性變化

體外受精（IVF）產業的結構正從分散的獨立診所轉變為整合的生育網路、醫院附屬生殖醫學中心和平台型服務模式。產業整合正在推動方案標準化、集中採購、資料基礎設施增強和檢查室品管更加統一。

人工智慧對體外受精（IVF）的累積影響

人工智慧（AI）正逐漸成為體外受精（IVF）整個價值鏈中切實可行的決策支援層。在胚胎學領域，人工智慧驅動的影像分析和延時監測技術正被用於胚胎分級、胚囊評估以及確保工作流程的一致性。在男性不孕症領域，電腦視覺工具正被評估用於規範精液分析和精子選擇。

關於體外受精（IVF）的關鍵區域見解

亞太地區是體外受精（IVF）市場最具活力的地區之一，這得益於其龐大的育齡人口、較晚的結婚年齡、都市化、部分經濟體出生率的下降以及人們對輔助生殖技術的日益了解。中國、印度、日本、韓國和澳洲是該地區的主要需求國，但在成本效益、監管和診所品質方面存在顯著差異。日本生育保險覆蓋範圍的擴大和印度私人生育網路的興起顯示了兩條截然不同的發展路徑：一是公共服務覆蓋範圍的擴大，二是私營部門的蓬勃發展。

關於體外受精（IVF）的關鍵群體特定見解

東協市場正受益於醫療旅遊、私立醫院集團的擴張以及人們對生育治療日益成長的認知，這一趨勢在泰國、新加坡、馬來西亞、越南和印尼尤為顯著。在生育治療、檢查室認證、海外患者服務以及臨床醫生培訓體係等方面監管完善的地區，市場成長尤為顯著。

各國體外受精（IVF）關鍵概況

美國是全球體外受精（IVF）商業性程度最高的市場，卵胞漿內單一精子注射（ICSI）、胚胎著床前遺傳學檢測、生育融資、雇主福利和多地點診所網路等技術已廣泛應用。根據美國疾病管制與預防中心（CDC）統計，輔助生殖技術在美國每年的新生兒出生中所佔比例雖小，但意義重大。加拿大擁有完善的臨床管治，但各省在資金上的差異影響了病患獲得治療的機會。墨西哥正逐漸成為北美患者經濟實惠的治療目的地，而巴西則是拉丁美洲規模最大、專家級最高、私人生殖健康醫療基礎設施最完善的生育市場。

為體外受精（IVF）產業領導者提供的實用建議

產業領導者應優先考慮透明且經風險調整後的治療結果報告，因為患者、保險公司和監管機構越來越傾向於根據出生率、安全性、降低多胎妊娠率和患者體驗來評估試管嬰兒服務提供者。診所應公佈易於理解的成功率指標，避免在不同年齡層、不孕症診斷和治療類型之間進行誤導性比較。

調查方法

本執行摘要是基於與體外受精相關的公共衛生、監管、臨床和產業指標的系統性回顧。主要參考文獻包括世界衛生組織 (WHO) 的不孕症盛行率估計、輔助生殖技術 (ART) 報告框架（例如美國疾病管制與預防中心 (CDC) 和英國人類受精與胚胎移植局 (HFEA)），以及來自專業組織（例如歐洲人類生殖與胚胎學會 (ESHRE) 和美國生殖醫學學會 (ASRM)）的生殖醫學指南。

結論

體外受精（IVF）正進入一個新階段，其特點是需求不斷成長、臨床期望不斷提高、監管更加嚴格以及新技術快速湧現。背後的長期因素包括全球不孕症的普遍性、母親生育年齡的成長、許多經濟體出生率的下降以及輔助生殖技術日益被人們接受。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 體外受精市場：依產品分類

  • 培養基
    • 冷凍保存介質
    • 胚胎培養基
    • 卵子處理培養基
    • 精子處理培養基
  • 一次性設備和配件
  • 裝置
    • 隔振台
    • 冷凍系統
    • 氣體分析儀
    • 影像系統
    • 培養箱
    • 試管嬰兒診所
    • 雷射系統
    • 微型機械手臂系統
    • 顯微鏡
    • 卵子抽吸泵
    • 精子分析系統
    • 精子分離裝置
    • 防止混淆的系統

第8章 體外受精市場：依胚胎來源分類

  • 新鮮捐贈者
  • 新鮮的，非捐贈者的
  • 冷凍捐贈者
  • 冷凍非捐贈者

第9章 體外受精市場：依手術類型分類

  • 輔助孵化
  • 常規體外受精（IVF）
  • 冷凍胚胎移植（FET）
  • 輸卵管內配子移植（GIFT）
  • 胞漿內單一精子注射（ICSI）
  • 受精卵輸卵管內移植（ZIFT）

第10章 體外受精市場：依應用領域分類

  • 女性不孕症
    • 子宮內膜異位症
    • 排卵障礙
    • 輸卵管因素不孕症
    • 不明原因不孕
  • 男性不孕
    • 精子形態異常
    • 精子數量減少
    • 精子活力下降

第11章 體外受精市場：依最終用戶分類

  • 門診手術中心
  • 不孕症治療診所
  • 醫院

第12章 體外受精市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 體外受精市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 體外受精市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Carl Zeiss AG
  • Cook Medical Inc.
  • CooperSurgical Inc.
  • Corning incorporated
  • Esco micro pte. Ltd.
  • Ferring BV
  • FertiPro NV
  • Genea Biomedx Pty Ltd.
  • Hamilton Thorne, Inc.
  • INVO Bioscience, Inc.
  • IVFtech ApS
  • Kitazato Corporation
  • Laboratoire CCD
  • Meiji Techno Co., Ltd.
  • Merck KGaA
  • Nidacon International AB
  • Nikon Corporation
  • Olympus Corporation
  • Thermo Fisher Scientific Inc.
  • Vitrolife AB
Product Code: MRR-43127F7279FE

The In-Vitro Fertilization Market is projected to grow by USD 27.49 billion at a CAGR of 10.81% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 13.40 billion
Estimated Year [2026] USD 14.78 billion
Forecast Year [2032] USD 27.49 billion
CAGR (%) 10.81%

Infertility has become a mainstream public-health and demographic issue. The World Health Organization estimates that approximately 1 in 6 adults experience infertility during their lifetime, supporting sustained demand for in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), fertility preservation, donor gametes, and preimplantation genetic testing where legally permitted.

Since the first IVF birth in 1978, assisted reproductive technology has resulted in more than 10 million births worldwide, according to estimates widely cited by ESHRE and ICMART. Demand is being shaped by delayed parenthood, rising maternal age, male-factor infertility, oncology-related fertility preservation, LGBTQ+ family-building pathways, and broader acceptance of reproductive medicine.

For industry leaders, IVF success increasingly depends on evidence-based outcomes, affordability, laboratory standardization, regulatory trust, and patient experience. Competitive advantage is shifting toward transparent success-rate reporting, digitally enabled care, secure reproductive health data systems, and scalable embryology operations that maintain quality across multiple sites.

Transformative Shifts in the IVF Landscape

The IVF landscape is shifting from fragmented independent clinics toward integrated fertility networks, hospital-affiliated reproductive centers, and platform-based service models. Consolidation is enabling standardized protocols, centralized procurement, stronger data infrastructure, and more consistent laboratory quality management.

Clinical demand is also changing. Patients are older on average in many developed markets, increasing the need for individualized ovarian stimulation, oocyte vitrification, advanced embryo assessment, fertility preservation, and genetic counseling. In emerging markets, awareness and private healthcare investment are expanding access to assisted reproductive technology, although affordability remains a major barrier.

Policy is a decisive growth factor. Countries with public funding or insurance coverage typically see broader access and higher utilization, while self-pay markets rely more heavily on premium services, financing, package pricing, and cross-border reproductive care. The strongest operators are aligning clinical quality with access models that reduce patient drop-off and improve continuity of care.

Cumulative Impact of Artificial Intelligence on IVF

Artificial intelligence is becoming a practical decision-support layer across the IVF value chain. In embryology, AI-assisted image analysis and time-lapse monitoring are being used to support embryo grading, blastocyst assessment, and workflow consistency. In andrology, computer vision tools are being evaluated for semen analysis and sperm-selection standardization.

The most measurable near-term impact is operational rather than fully autonomous clinical decision-making. AI can reduce inter-observer variability, flag laboratory anomalies, optimize scheduling, improve medication adherence, and personalize patient communication, especially in high-volume fertility networks.

Adoption must remain evidence-led. IVF algorithms require external validation across diverse patient populations, transparent performance reporting, bias testing, cybersecurity safeguards, and compliance with health-data and medical-device regulations. Clinics that use AI under physician and embryologist oversight are best positioned to build trust and measurable value in assisted reproductive technology.

Key Regional Insights for IVF

Asia-Pacific is one of the most dynamic IVF regions because of large reproductive-age populations, delayed marriage, urbanization, declining fertility rates in several economies, and rising awareness of assisted reproductive technology. China, India, Japan, South Korea, and Australia anchor demand, while affordability, regulation, and clinic quality vary widely. Japan's expanded fertility insurance coverage and India's growing private fertility networks show two distinct pathways: public access expansion and private-sector scale.

North America remains a high-value IVF region led by the United States and Canada. The United States benefits from advanced embryology, broad use of ICSI and preimplantation genetic testing, employer fertility benefits, and strong patient willingness to pay, but access remains uneven because insurance mandates vary by state. Canada has strong clinical standards and selective provincial funding, although eligibility rules and wait times influence treatment utilization.

Europe combines mature clinical expertise with significant regulatory diversity. The United Kingdom, Germany, France, Italy, and Spain have established fertility ecosystems, but reimbursement, donor rules, embryo testing restrictions, cryostorage requirements, and age limits differ materially. Spain remains a leading destination for cross-border reproductive care because of donor-program capacity, specialized clinic infrastructure, and permissive rules for selected treatment pathways.

Latin America is gaining momentum, with Brazil and Mexico serving as important hubs for private fertility care and medical travel. The Middle East is expanding through GCC investment in women's health, premium hospitals, and medical tourism, while religious and legal frameworks strongly influence treatment options. Africa remains underpenetrated despite a substantial infertility burden, with access constrained by cost, infrastructure, stigma, limited specialist availability, and uneven distribution of embryology laboratories.

Key Group Insights for IVF

ASEAN markets are benefiting from medical tourism, expanding private hospital groups, and growing awareness of infertility treatment, especially in Thailand, Singapore, Malaysia, Vietnam, and Indonesia. Growth is strongest where fertility regulation, laboratory accreditation, international patient services, and clinician training pathways are clearly established.

The GCC is investing in advanced healthcare infrastructure, women's health services, and specialist reproductive medicine. Cultural, religious, and legal frameworks shape IVF pathways, particularly around donor gametes, embryo handling, genetic testing, and surrogacy, making localized compliance essential for fertility clinic operators, laboratory suppliers, and reproductive technology vendors.

The European Union provides a sophisticated but highly regulated IVF environment. GDPR governs reproductive health data, while medical-device, tissue-handling, laboratory, and clinical governance requirements influence AI tools, culture media, genetic testing, cryostorage systems, and digital patient platforms. BRICS countries represent long-term scale, with China, India, and Brazil especially important, although affordability, infrastructure quality, and regulatory oversight remain decisive.

G7 countries lead in clinical research, premium fertility technology, outcome reporting, and payer innovation, but face aging populations, delayed parenthood, and cost-access challenges. NATO is not a fertility-policy bloc; however, many member countries share advanced healthcare infrastructure, cybersecurity priorities, and military-family health considerations that can affect reproductive health service planning and fertility benefit design.

Key Country Insights for IVF

The United States is the world's most commercially advanced IVF market, with extensive use of ICSI, preimplantation genetic testing, fertility financing, employer benefits, and multi-site clinic networks; CDC reporting shows assisted reproductive technology accounts for a small but meaningful share of U.S. births each year. Canada offers strong clinical governance, though provincial funding differences shape access. Mexico is growing as a cost-competitive destination for North American patients, while Brazil is Latin America's largest fertility market by scale, specialist capacity, and private reproductive medicine infrastructure.

In Europe, the United Kingdom combines HFEA oversight with a sophisticated private market, although NHS funding varies by location. Germany has strict embryo-protection rules and selective reimbursement, while France expanded access to assisted reproduction for single women and female couples. Russia has historically had significant ART capacity, Italy operates within evolving legal constraints, and Spain is a major hub for donor-assisted IVF and cross-border reproductive care.

In Asia-Pacific, China represents major demand potential due to demographic pressure, delayed childbearing, and expanding reproductive medicine capacity. India is scaling through private fertility chains, value-oriented medical care, and growing awareness beyond major metropolitan centers. Japan has high treatment utilization linked to delayed childbearing and policy support, while South Korea combines advanced healthcare infrastructure with very low fertility rates. Australia is a mature, well-regulated IVF market with strong outcome reporting, public-private participation, and established fertility preservation services.

Actionable Recommendations for IVF Industry Leaders

Industry leaders should prioritize transparent, risk-adjusted outcome reporting because patients, payers, and regulators increasingly evaluate IVF providers on live-birth outcomes, safety, multiple-pregnancy reduction, and patient experience. Clinics should publish understandable success-rate metrics while avoiding misleading comparisons across age groups, infertility diagnoses, and treatment types.

Operational excellence in the embryology laboratory is essential. Leaders should invest in validated culture systems, quality management, temperature and air-quality monitoring, chain-of-custody safeguards, cryostorage risk controls, emergency preparedness, and continuous embryologist training. Standardized protocols are especially important for multi-site fertility networks.

Commercial strategy should focus on access and trust. Financing options, fertility benefits partnerships, employer programs, multilingual patient navigation, counseling support, and evidence-based digital engagement can reduce treatment drop-off. AI should be deployed only through validated use cases, with human oversight, bias testing, audit trails, cybersecurity controls, and clear patient communication embedded from the start.

Research Methodology

This executive summary is based on a structured review of public-health, regulatory, clinical, and industry indicators relevant to in-vitro fertilization. Core reference points include infertility prevalence estimates from the World Health Organization, ART reporting frameworks such as the CDC in the United States and HFEA in the United Kingdom, and reproductive medicine guidance from professional bodies including ESHRE and ASRM.

The analysis prioritizes verified signals, including demographic fertility trends, maternal-age patterns, reimbursement structures, regulatory rules, clinic-network expansion, cross-border reproductive care, laboratory technology adoption, quality management practices, and AI validation requirements. Regional, group, and country insights are synthesized from public sources and established industry patterns rather than unsupported projections.

Because IVF regulation and reimbursement can change quickly, findings should be interpreted as an executive-level industry view rather than legal or clinical advice. Market-entry, investment, and product-launch decisions should be supported by country-specific regulatory review, payer analysis, ethical assessment, and clinical expert validation.

Conclusion

In-vitro fertilization is entering a new phase defined by broader demand, higher clinical expectations, stronger regulation, and rapid technology adoption. Long-term fundamentals are supported by global infertility prevalence, delayed parenthood, declining birth rates in many economies, and growing acceptance of assisted reproduction.

The most successful organizations will combine medical credibility with operational scale. Clinics, laboratories, technology vendors, and investors that deliver evidence-based outcomes, accessible pricing, secure data systems, and patient-centered care will be best positioned to build sustainable leadership in IVF services.

AI, genetic testing, cryopreservation, and digital care platforms will continue to reshape IVF, but trust will remain the industry's core asset. Sustainable leadership will depend on balancing innovation with ethical practice, regulatory compliance, and measurable improvements in live-birth outcomes and patient safety.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. In-Vitro Fertilization Market, by Product

  • 7.1. Culture Media
    • 7.1.1. Cryopreservation Media
    • 7.1.2. Embryo Culture Media
    • 7.1.3. Ovum Processing Media
    • 7.1.4. Sperm Processing Media
  • 7.2. Disposable Devices & accessories
  • 7.3. Equipment
    • 7.3.1. Anti-vibration Tables
    • 7.3.2. Cryosystems
    • 7.3.3. Gas Analyzers
    • 7.3.4. Imaging Systems
    • 7.3.5. Incubators
    • 7.3.6. IVF Cabinets
    • 7.3.7. Laser Systems
    • 7.3.8. Micromanipulator Systems
    • 7.3.9. Microscopes
    • 7.3.10. Ovum Aspiration Pumps
    • 7.3.11. Sperm Analyzer Systems
    • 7.3.12. Sperm Separation Devices
    • 7.3.13. Witness Systems

8. In-Vitro Fertilization Market, by Embryo Source

  • 8.1. Fresh Donor
  • 8.2. Fresh Non-donor
  • 8.3. Frozen Donor
  • 8.4. Frozen Non-donor

9. In-Vitro Fertilization Market, by Procedure Type

  • 9.1. Assisted Hatching
  • 9.2. Conventional IVF
  • 9.3. Frozen Embryo Transfer (FET)
  • 9.4. Gamete Intrafallopian Transfer (GIFT)
  • 9.5. Intracytoplasmic Sperm Injection (ICSI)
  • 9.6. Zygote Intrafallopian Transfer (ZIFT)

10. In-Vitro Fertilization Market, by Application

  • 10.1. Female Infertility
    • 10.1.1. Endometriosis
    • 10.1.2. Ovulatory Disorders
    • 10.1.3. Tubal Factor Infertility
    • 10.1.4. Unexplained Infertility
  • 10.2. Male Infertility
    • 10.2.1. Abnormal Sperm Morphology
    • 10.2.2. Low Sperm Count
    • 10.2.3. Poor Sperm Motility

11. In-Vitro Fertilization Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Fertility Clinics
  • 11.3. Hospitals

12. In-Vitro Fertilization Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. In-Vitro Fertilization Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. In-Vitro Fertilization Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Carl Zeiss AG
  • 16.2. Cook Medical Inc.
  • 16.3. CooperSurgical Inc.
  • 16.4. Corning incorporated
  • 16.5. Esco micro pte. Ltd.
  • 16.6. Ferring B.V.
  • 16.7. FertiPro N.V.
  • 16.8. Genea Biomedx Pty Ltd.
  • 16.9. Hamilton Thorne, Inc.
  • 16.10. INVO Bioscience, Inc.
  • 16.11. IVFtech ApS
  • 16.12. Kitazato Corporation
  • 16.13. Laboratoire CCD
  • 16.14. Meiji Techno Co., Ltd.
  • 16.15. Merck KGaA
  • 16.16. Nidacon International AB
  • 16.17. Nikon Corporation
  • 16.18. Olympus Corporation
  • 16.19. Thermo Fisher Scientific Inc.
  • 16.20. Vitrolife AB

LIST OF FIGURES

  • FIGURE 1. GLOBAL IN-VITRO FERTILIZATION MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL IN-VITRO FERTILIZATION MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL IN-VITRO FERTILIZATION MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL IN-VITRO FERTILIZATION MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO FERTILIZATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL IN-VITRO FERTILIZATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CULTURE MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CULTURE MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CRYOPRESERVATION MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CRYOPRESERVATION MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CRYOPRESERVATION MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EMBRYO CULTURE MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL EMBRYO CULTURE MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL EMBRYO CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL OVUM PROCESSING MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL OVUM PROCESSING MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL OVUM PROCESSING MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SPERM PROCESSING MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SPERM PROCESSING MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SPERM PROCESSING MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DISPOSABLE DEVICES & ACCESSORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DISPOSABLE DEVICES & ACCESSORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DISPOSABLE DEVICES & ACCESSORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANTI-VIBRATION TABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANTI-VIBRATION TABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANTI-VIBRATION TABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CRYOSYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CRYOSYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CRYOSYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GAS ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GAS ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GAS ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INCUBATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INCUBATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INCUBATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IVF CABINETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IVF CABINETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IVF CABINETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LASER SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LASER SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LASER SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MICROMANIPULATOR SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MICROMANIPULATOR SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MICROMANIPULATOR SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MICROSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MICROSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MICROSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL OVUM ASPIRATION PUMPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL OVUM ASPIRATION PUMPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL OVUM ASPIRATION PUMPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SPERM ANALYZER SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SPERM ANALYZER SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SPERM ANALYZER SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SPERM SEPARATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SPERM SEPARATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SPERM SEPARATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL WITNESS SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL WITNESS SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL WITNESS SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FRESH DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FRESH DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FRESH DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FRESH NON-DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FRESH NON-DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FRESH NON-DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FROZEN DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FROZEN DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FROZEN DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FROZEN NON-DONOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FROZEN NON-DONOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FROZEN NON-DONOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ASSISTED HATCHING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ASSISTED HATCHING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ASSISTED HATCHING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CONVENTIONAL IVF MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CONVENTIONAL IVF MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CONVENTIONAL IVF MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FROZEN EMBRYO TRANSFER (FET) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FROZEN EMBRYO TRANSFER (FET) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FROZEN EMBRYO TRANSFER (FET) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GAMETE INTRAFALLOPIAN TRANSFER (GIFT) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GAMETE INTRAFALLOPIAN TRANSFER (GIFT) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GAMETE INTRAFALLOPIAN TRANSFER (GIFT) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRACYTOPLASMIC SPERM INJECTION (ICSI) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INTRACYTOPLASMIC SPERM INJECTION (ICSI) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRACYTOPLASMIC SPERM INJECTION (ICSI) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ZYGOTE INTRAFALLOPIAN TRANSFER (ZIFT) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ZYGOTE INTRAFALLOPIAN TRANSFER (ZIFT) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ZYGOTE INTRAFALLOPIAN TRANSFER (ZIFT) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL FEMALE INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FEMALE INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL FEMALE INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ENDOMETRIOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL OVULATORY DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL OVULATORY DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL OVULATORY DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL TUBAL FACTOR INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL TUBAL FACTOR INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL TUBAL FACTOR INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL UNEXPLAINED INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL UNEXPLAINED INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL UNEXPLAINED INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MALE INFERTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MALE INFERTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MALE INFERTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ABNORMAL SPERM MORPHOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ABNORMAL SPERM MORPHOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ABNORMAL SPERM MORPHOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL LOW SPERM COUNT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL LOW SPERM COUNT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL LOW SPERM COUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL POOR SPERM MOTILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL POOR SPERM MOTILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL POOR SPERM MOTILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL FERTILITY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL FERTILITY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL FERTILITY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. GCC IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 207. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 208. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 209. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 213. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 214. GCC IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. G7 IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 237. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 238. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 239. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 240. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 243. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 244. G7 IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. NATO IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 247. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 248. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 249. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 253. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 254. NATO IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL IN-VITRO FERTILIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. CANADA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 267. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 268. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 269. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 270. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 271. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 274. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 275. CANADA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 278. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 279. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 280. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 281. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 283. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 284. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 285. MEXICO IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 286. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 288. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 289. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 290. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 291. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 294. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 295. BRAZIL IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED KINGDOM IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 306. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 307. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 308. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 309. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 310. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 311. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 313. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 314. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 315. GERMANY IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 316. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 317. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 318. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 319. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 320. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 321. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 323. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 324. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 325. FRANCE IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 326. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 327. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 328. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 329. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 330. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 331. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 333. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 334. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 335. RUSSIA IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 336. ITALY IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 337. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 338. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 339. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 340. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 341. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 342. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 343. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 344. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 345. ITALY IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 346. SPAIN IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 347. SPAIN IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 348. SPAIN IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 349. SPAIN IN-VITRO FERTILIZATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 350. SPAIN IN-VITRO FERTILIZATION MARKET SIZE, BY EMBRYO SOURCE, 2018-2032 (USD MILLION)
  • TABLE 351. SPAIN IN-VITRO FERTILIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 352. SPAIN IN-VITRO FERTILIZATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 353. SPAIN IN-VITRO FERTILIZATION MARKET SIZE, BY FEMALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 354. SPAIN IN-VITRO FERTILIZATION MARKET SIZE, BY MALE INFERTILITY, 2018-2032 (USD MILLION)
  • TABLE 355. SPAIN IN-VITRO FERTILIZATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 356. CHINA IN-VITRO FERTILIZATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 357. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 358. CHINA IN-VITRO FERTILIZATION MARKET SIZE, BY CULTURE MEDIA, 2018-2032 (USD MILLION)
  • TABLE 359. CHINA IN-VITRO FERTILIZATION